Home
Clinical Resources Search
PQI: Use of Rasburicase (Elitek®) for Treatment of Tumor Lysis Syndrome

Use of Rasburicase (Elitek®) for Treatment of Tumor Lysis Syndrome

Download PQI pdf 0.15MB

Last Updated: September 27, 2022

By: Marie C. Rush, PharmD, CPP, BCOP

About this PQI

The purpose of this PQI is to identify appropriate dosing of rasburicase based upon uric acid levels.

More About This PQI

PQI in Action Articles:

PQI_elitek_treatment_tumor_lysis pdf 1.21MB

How to Use a Positive Quality Intervention (PQI)

Essentially, it’s a tool to improve patient care by sharing best practices in oncology care. Consider this standardized, peer-review clinical guidance to oncology healthcare teams, enabling you and your team to consistently deliver high-quality care to your patients.

Find a PQI

Find Similar Resources

All Resources

PQI PQI in Action PQI Podcast Toolkit Treatment Support Kit Video Acute Myeloid Leukemia (AML) Chronic Lymphocityic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) Hematological Malignancies Tumor Lysis Syndrome (TLS) Elitek Rasburicase

PQI

PQI: Ibrutinib Dosing Optimization

Author: Nick Bouchard, PharmD | Danielle Maciorowski, PharmD

Frequently Searched

Supported by

Use of Rasburicase (Elitek®) for Treatment of Tumor Lysis Syndrome

About this PQI

More About This PQI

PQI in Action Articles:

How to Use a Positive Quality Intervention (PQI)

Find Similar Resources

PQI: Ibrutinib Dosing Optimization

PQI: Zanubrutinib (Brukinsa®) Patient Selection and Management

PQI: Zanubrutinib (Brukinsa ®) treatment for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

PQI: Vorasidenib (Voranigo®)

PQI in Action: Tepotinib (Tepmetko®) for Non-Small Cell Lung Cancerwith MET Exon 14 Alterations

PQI in Action: Siltuximab (Sylvant®) in Patients with Idiopathic Multicentric Castleman Disease

PQI in Action: Isatuximab-irfc (Sarclisa®) in 1q21 Gain or Amplifications in Relapsed/Refractory Multiple Myeloma

PQI in Action: Adagrasib (Krazati®)

The PQI Podcast S3 Ep 11: Moffitt Clinical Pharmacy Program

The PQI Podcast S3 Ep 12: Health Disparities in Cancer Screenings

The PQI Podcast S3 Ep 13: The Importance of the Multidisciplinary Team

The PQI Podcast S3 Ep 14: The Venetoclax PQI and AML Updates

Readiness Tracker

Treatment Support Kit: Abemaciclib

Treatment Support Kit: Temozolomide

Treatment Support Kit: Tivozanib

Treatment Support Kit: Regorafenib

Video: BRUKINSA® (Zanubrutinib) for Treatment of Relapsed or Refractory Marginal Zone Lymphoma

Video: BRUKINSA® (Zanubrutinib) for Treatment of Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)

Video: BRUKINSA® (Zanubrutinib) for Treatment of Mantle Cell Lymphoma

Video: BRUKINSA® (Zanubrutinib) for Treatment of Waldenstrom’s Macroglobulinemia

PQI: Venetoclax (Venclexta®) for the Treatment of Acute Myeloid Leukemia

PQI: Optimizing Venetoclax Treatment of Acute Myeloid Leukemia

PQI: Liposomal Daunorubicin-Cytarabine (Vyxeos®) Management

PQI Podcast S5 Ep 10: Pharmacy Path & NCODA Venetoclax Resources

Video: BRUKINSA® (Zanubrutinib) for Treatment of Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)

PQI: Ibrutinib Dosing Optimization

PQI: Zanubrutinib (Brukinsa ®) treatment for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

PQI: Venetoclax (Venclexta®) Use in Chronic Lymphocytic Leukemia

PQI Podcast S7 Ep 8: Sickle Cell Disease Insights

PQI: Venetoclax (Venclexta®) Use in Chronic Lymphocytic Leukemia

PQI: Venetoclax (Venclexta®) for the Treatment of Acute Myeloid Leukemia

PQI in Action: Use of Rasburicase (Elitek®) For Treatment of Tumor Lysis Syndrome

PQI in Action: Use of Rasburicase (Elitek®) For Treatment of Tumor Lysis Syndrome

PQI in Action: Use of Rasburicase (Elitek®) For Treatment of Tumor Lysis Syndrome

PQI in Action: Zanubrutinib (Brukinsa®) Patient Selection and Management in Mantle Cell Lymphoma – 2

PQI in Action: Zanubrutinib (Brukinsa®) Patient Selection and Management in Mantle Cell Lymphoma

The PQI Podcast S3 Ep 11: Moffitt Clinical Pharmacy Program

The PQI Podcast S3 Ep 12: Health Disparities in Cancer Screenings

The PQI Podcast S3 Ep 13: The Importance of the Multidisciplinary Team

The PQI Podcast S3 Ep 14: The Venetoclax PQI and AML Updates